RetractedArticleBritish journal of cancer2014

Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.

S J Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.